Paper Details

  1. Home
  2. Paper Details

The "newer" progestogens and postmenopausal hormone therapy (HRT).

Author: SchindlerAdolf E

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

This review discusses the use of newer progestogens, such as dienogest, drospirenone, and nomegestrol acetate, in hormone therapy for women. These progestogens are being explored as potentially safer alternatives to older progestogens.
Paper Details　
Original Abstract of the Article :
After a worldwide breakdown of hormone therapy [HT] following the publications of the Women's Health Initiative trial and Million Women's Study in 2002-2003, there is now a trend to turn attention again to HT and to explore particular progestogens, which have been discredited with respect to their s...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.jsbmb.2013.12.003

データ提供：米国国立医学図書館（NLM）

Newer Progestogens: A New Chapter in Hormone Therapy

The landscape of hormone therapy, like a shifting desert, is constantly evolving. Researchers are exploring new and safer ways to address the needs of women during menopause, seeking solutions like a hidden oasis in the desert. This review focuses on newer progestogens, a type of hormone, used in combination with estrogen for hormone therapy.

The researchers discuss the potential benefits and risks of three specific progestogens – dienogest, drospirenone, and nomegestrol acetate – in combination with estradiol. They highlight the importance of choosing progestogens that effectively control endometrial proliferation without negatively impacting other health benefits of estrogen.

Newer Progestogens: A More Balanced Approach

This review suggests that newer progestogens, in combination with estrogen, may offer a more balanced approach to hormone therapy, addressing both menopausal symptoms and potential risks. This is a promising development, like discovering a new water source in the desert that provides both hydration and nourishment.

Navigating the Menopause Landscape

This review offers valuable insights for women navigating the menopause landscape. It highlights the importance of choosing appropriate progestogens, tailored to individual needs and health concerns. This information, like a well-charted map, can help women make informed decisions about their health and well-being.

Dr.Camel's Conclusion

This review sheds light on the evolving landscape of hormone therapy. Newer progestogens offer a more balanced approach to managing menopausal symptoms, addressing both benefits and risks. This discovery, like finding a hidden oasis in the desert of menopause, provides a potential path to a more comfortable and fulfilling experience for women.

Date :
  1. Date Completed 2014-06-19
  2. Date Revised 2014-11-20
Further Info :

Pubmed ID

24333799

DOI: Digital Object Identifier

10.1016/j.jsbmb.2013.12.003

Related Literature

Article Analysis
・Side Effects of megestrol
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.